Ambulatory vasoactivity monitor
Systems and methods for monitoring patient vasoactivity are discussed. An exemplary patient monitor system includes a sensor circuit configured to generate a heart sound (HS) metric using a HS signal sensed from a patient, and a vasoactivity monitor configured to monitor vasoactivity, such as degree of vasoconstriction or vasodilation, using the HS metric. The system can provide the monitored vasoactivity to a user to alert patient hemodynamic responses to vasoactive drugs, or initiate or adjust a vasoactive therapy according to the vasoactivity. The system may use the monitored vasoactivity to detect a medical condition such as worsening heart failure, pulmonary edema, or syncope.
1. A system for ambulatory monitoring of vasoactivity in a patient, comprising:
a sensor circuit configured to generate a heart sound (HS) metric using a HS signal sensed from the patient; and
a control circuit, including: a vasoactivity monitor configured to monitor vasoactivity and determine a degree of vasodilation using the generated HS metric; and a vasovagal surge detector configured to detect a vasovagal surge using the determined degree of vasodilation.
2. The system of claim 1 , wherein the vasoactivity monitor is configured to detect the vasovagal surge in response to a vasodilator or vasoconstrictor therapy, and to generate a therapy efficacy indicator using the monitored vasoactivity.
3. The system of claim 1 , comprising a therapy unit configured to generate or adjust a vasoactive therapy according to the monitored vasoactivity.
4. The system of claim 1 , wherein the sensor circuit is configured to generate a HS metric using one or more HS components including first (S1), second (S2), third (S3), or fourth (S4) HS components detected from the sensed HS signal.
5. The system of claim 4 , wherein the HS metric includes a S2 intensity and the vasoactivity monitor is configured to detect the vasovagal surge using an increase in S2 intensity.
6. The system of claim 5 , wherein the HS metric further includes a S1 intensity, and the vasoactivity monitor is configured to detect the vasovagal surge using an increase in S1 intensity concurrent with the increase in S2 intensity.
7. The system of claim 1 , comprising a target event detector configured to detect a syncope or a pre-syncope using the detected vasovagal surge.
8. A system for ambulatory monitoring of vasoactivity in a patient, the system comprising:
a sensor circuit configured to generate a heart sound (HS) metric using a HS signal sensed from the patient; and
a control circuit, including: a vasoactivity monitor configured to monitor vasoactivity and determine a degree of vasoconstriction using the generated HS metric; and a sympathetic surge detector configured to detect a sympathetic surge using the determined degree of vasoconstriction.
9. The system of claim 8 , comprising a target event detector configured to detect a pulmonary edema event using the detected sympathetic surge.
10. The system of claim 8 , comprising a target event detector configured to detect a worsening heart failure (WHF) event using the detected sympathetic surge.
11. The system of claim 8 , wherein the sensor circuit is configured to generate a HS metric using one or more HS components including first (S1), second (S2), third (S3), or fourth (S4) HS components detected from the sensed HS signal.
12. The system of claim 11 , wherein the HS metric includes a S2 intensity, and the vasoactivity monitor is configured to detect the sympathetic surge using a decrease in S2 intensity.
13. The system of claim 12 , wherein the HS metric further includes a S1 intensity, and the vasoactivity monitor is configured to detect the sympathetic surge using a decrease in S1 intensity concurrent with the decrease in S2 intensity.
14. The system of claim 11 , wherein the vasoactivity monitor is configured to detect the sympathetic surge in response to a vasodilator or vasoconstrictor therapy, and to generate a therapy efficacy indicator using the monitored vasoactivity.
15. A system for ambulatory monitoring of vasoactivity in a patient, comprising:
a sensor circuit configured to generate a heart sound (HS) metric using a HS signal sensed from the patient;
a control circuit, including a vasoactivity monitor configured to monitor vasoactivity and to detect a vasovagal surge using the generated HS metric; and
a target event detector configured to detect a worsening heart failure (WHF) event based at least in part on the monitored vasoactivity.
16. The system of claim 15 , wherein the sensor circuit is configured to generate a S2 intensity metric, and wherein the vasoactivity monitor is configured to detect the vasovagal surge using an increase in S2 intensity metric.
17. The system of claim 16 , wherein the sensor circuit is further configured to generate a S1 intensity metric, and the vasoactivity monitor is configured to detect the vasovagal surge using an increase in S1 intensity metric concurrent with the increase in S2 intensity metric.
18. A system for ambulatory monitoring of vasoactivity in a patient, the system comprising:
a sensor circuit configured to generate a heart sound (HS) metric using a HS signal sensed from the patient;
a control circuit, including a vasoactivity monitor configured to monitor vasoactivity and to detect a sympathetic surge using the generated HS metric; and
a target event detector configured to detect a worsening heart failure (WHF) event using the detected sympathetic surge.
19. The system of claim 18 , wherein the sensor circuit is configured to generate a S2 intensity metric, and the vasoactivity monitor is configured to detect the sympathetic surge using a decrease in S2 intensity metric.
20. The system of claim 19 , wherein the sensor circuit is further configured to generate a S1 intensity metric, and the vasoactivity monitor is configured to detect the sympathetic surge using a decrease in S1 intensity metric concurrent with the decrease in S2 intensity metric.